Edesa Biotech Inc expected to post a loss of 20 cents a share - Earnings Preview

Edesa Biotech

10/02/2023 16:34

* Edesa Biotech Inc  EDSA.OQ   EDSA.O  is expected to show
no
change in quarterly revenue when it reports  results on February
10. 
    * 
    * ​Refinitiv's mean analyst estimate for Edesa Biotech Inc
is for
a loss of 20 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "Buy".​
    * Wall Street's median 12-month price target for Edesa
Biotech Inc
is $13​, above​ its last closing price of $1.43. ​​​

This summary was machine generated February 10 at 16:34 GMT. 
All figures in US dollars  unless otherwise stated